Découvrez comment réduire la variabilité des flux de trésorerie à long terme grâce à notre solution de couverture en couches

Industrie Pharmaceutique

Centralise intercompany exposure, automate layered hedging, and eliminate EBITDA volatility across global production and distribution subsidiaries.

Speak with a Pharma FX Specialist

Why manual FX management fails pharma groups at scale

Global pharmaceutical groups face structural FX risks that manual treasury workflows cannot effectively manage.

Intercompany exposure
Each transaction between production and distribution entities creates an internal FX exposure — one that compounds before it surfaces in your P&L.
The "EBITDA Cliff"
R&D cycles require budget rates to hold for 24+ months. Relying on monthly ERP downloads means you are 30 days late to every market move, leading to sudden hits to operating profit.
Fragmentation & Friction
Lack of real-time visibility into subsidiary-level data results in over-hedging and excessive bank spreads. HQ treasury lacks the data for strategic forecasting while buried in manual consolidation.

Optimisez les points de terme

Utilisez un système automatisé permettant de repousser la prise de couverture et donc de réduire l’impact défavorable des points de terme sur la couverture de vos ventes à l’international.

Comptabilité

Automatisez facilement les tâches manuelles de la comptabilité de couverture; les informations pertinentes sont immédiatement collectées par Kantox Dynamic Hedging®.

Secure your group-wide profit margins

Review how our FX automation models align with your current intercompany flow and budget cycle.

Speak with a Pharma FX Specialist